600750.SH
华润江中
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.52
−8.53%Margins
Gross margin
65.2%
EBITDA margin
33.2%
EBIT margin
29.5%
Net margin
22.3%
FCF margin
13.3%
21.1%
Return on equity
12.7%
Return on assets
27.8%
Return on invested capital
0.58x
Asset turnover
CNY 826.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026